Intrinsic value of Cytokinetics, Incorporated (CYTK)

Live fair value data for Cytokinetics, Incorporated (CYTK) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Downside: -22.0%

Margin of Safety: -28.2%

Current Price: $205.00

Valuation: Overvalued

Confidence: 6.5/10

Visual Bar

Market Price $205.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is Cytokinetics, Incorporated (CYTK) undervalued or overvalued?

Based on the current model output, Cytokinetics, Incorporated appears to be overvalued with a downside of 22.00%.

Fair value vs market price — Cytokinetics, Incorporated (CYTK)

Unlock premium access to view the live fair value comparison against current market price for CYTK.

Frequently Asked Questions - CYTK

How is CYTK intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for CYTK.

Is CYTK undervalued or overvalued right now?

CYTK is currently shown as overvalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for CYTK: open their intrinsic value pages.

Explore Other Stocks